Acute Undifferentiated Leukemia — Trials

Acute Undifferentiated Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

40 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 11
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 18%
Top sponsor: Fred Hutchinson Cancer Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01028716	Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies	terminated	Phase 2	46	Fred Hutchinson Cancer CenterOTHER	1	Jan 23, 2023	clinicaltrials
NCT04044560	Blinatumomab for MRD in Pre-B ALL Patients Following Stem Cell Transplant(OZM-097)	terminated	Phase 2	8	University of British ColumbiaOTHER	1	Feb 21, 2022	clinicaltrials